… stage I non-small cell lung cancer (NSCLC) … NSCLC tumors. Additionally radiotherapy should
be offered in patients with N2 lymph nodes. In advanced stage IIIB/IV or inoperable NSCLC …

… Of the cases included in the study, 67,725 were NSCLC and 13,290 were small cell lung
cancers (SCLC). Patients were followed up for five-years and survival was measured from the …

… , V-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue; NSCLC-NOS, non-small-cell
lung cancer-not otherwise specified; ROS1, ROS proto-oncogene 1, receptor tyrosine kinase. …

… Although all major histological subtypes of NSCLC, as well as small cell lung cancer (SCLC),
are associated with smoking, the association is stronger with LUSC and SCLC than LUAD, …

… lung cancer will be diagnosed, of which the majority of patients are non-small cell lung
cancer (NSCLC… Historically, patients with advanced stage NSCLC were treated with platinum …

… In summary, the standard therapy for patients with unresectable stage III NSCLC remains
concurrent chemoradiotherapy, even though patients with stage III are highly variable and …

… , and more poorly differentiated variants, a key recent advance is the increasing refinement
of a pathological diagnosis of NSCLC-NOS (not otherwise specified) whenever possible. …

… to have small cell lung cancer (ICD-0-3 histology code 8041–8045). In addition, patients
without pathologic diagnosis of NSCLC and American Joint Committee on Cancer staging …

… Lung cancer remains the leading cause of cancer deaths. Non-small cell lung cancer (NSCLC)
is the most frequent subtype of lung cancer. Surgery, radiation, chemotherapy, …

… Lung cancer is the most common cause of cancer deaths worldwide. The two broad histological
subtypes of lung cancer are small-cell lung cancer (… -cell lung cancer (NSCLC) which is …